Artel Further Enhances ArtelWare™ Software to Provide Liquid Handler Performance Trending
November 13, 2014
Westbrook, Maine -– Artel, the leader in liquid handling quality assurance, introduces ArtelWare v1.2, adding sophisticated tools for liquid handler monitoring with the company’s MVS® Multichannel Verification System. With new, color-coded heat maps for relative inaccuracy and %CV, users can view performance trends over the microplate. These new tools build on other recent ArtelWare enhancements [...]
Connecticut Innovations Portfolio Company CyVek Acquired by Bio-Techne
November 13, 2014
ROCKY HILL, Conn. -– Connecticut Innovations (CI), the leading source of financing and ongoing support for Connecticut’s innovative, growing companies, today announced that Bio-Techne, a company engaged in the development, manufacture and sale of biotechnology products and clinical calibrators and controls, successfully completed the acquisition of a CI portfolio company, CyVek. Connecticut Innovations invested approximately [...]
Roche Receives FDA Clearance for Strep A Test on cobas Liat System
November 13, 2014
Basel -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance for the cobas® Strep A test for the detection of group A streptococcus bacterial (Strep A) DNA in throat swab specimens. The cobas Strep A test runs on the cobas Liat System, a [...]
Malvern releases new guidance on the use of automated imaging for agglomerate detection
November 13, 2014
Malvern, UK: Malvern Instruments has released new guidance on using automated image analysis to detect and quantify agglomerates. The ability of uncontrolled agglomeration to substantially impact the performance and value of powder products makes efficient agglomerate detection vital across a number of industries. ‘Identification of agglomerates using automated image analysis’ presents practical strategies for efficiently [...]
Cepheid To Develop Xpert Ebola For Countries Worst Hit By Epidemic
November 13, 2014
SUNNYVALE, Calif. -- Cepheid (NASDAQ: CPHD) today announced that it has been awarded a grant of up to $3.3 million co-financed by the Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation to develop Xpert® Ebola, a rapid test that could be run on Cepheid's installed base of more than 3,500 GeneXpert® [...]
Fluorescence-based Mitochondria / Metabolism Assays
November 13, 2014
AMSBIO has signed a strategic marketing agreement with Luxcel Biosciences to distribute their range of 96- and 384-well phosphorescence and fluorescence based assays. These new assay kits enable direct real-time analysis of Mitochondrial Respiration (MitoXpress® Xtra), Glycolysis (pH-Xtra®) and Intracellular Oxygen Concentration (MitoXpress® Intra) – providing the perfect tool kit for monitoring bioenergentics, metabolism, Warburg [...]
Artel Further Enhances ArtelWare™ Software to Provide Liquid Handler Performance Trending
November 13, 2014
Westbrook, Maine -– Artel, the leader in liquid handling quality assurance, introduces ArtelWare v1.2, adding sophisticated tools for liquid handler monitoring with the company’s MVS® Multichannel Verification System. With new, color-coded heat maps for relative inaccuracy and %CV, users can view performance trends over the microplate. These new tools build on other recent ArtelWare enhancements [...]
Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan
November 12, 2014
SEATTLE -- ReachBio Research Labs (a registered trade name of ReachBio LLC, Seattle, WA) announced today that it has signed an agreement with Funakoshi Co., Ltd. (Tokyo, Japan), giving Funakoshi non-exclusive distribution rights to ReachBio's human primary cell product line for the life science research market within Japan. Under a companion agreement, Funakoshi will also [...]
November 12, 2014
Singapore -– Vela Diagnostics announced today that it has completed the listing of its Next-Generation Sequencing (NGS) system with the U.S. Food and Drug Administration (FDA) for clinical use as a class II device. The Vela Diagnostics NGS System comprises the Sentosa® ST401 instruments which provide an automated solution for template preparation and enrichments, the [...]
Susan A. Willetts Joins Cellular Dynamics’ Board of Directors
November 12, 2014
MADISON, Wis. -- Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Susan A. Willetts was elected to the company's board of directors, effective November 6, 2014. Ms. Willetts also will serve as a member of the CDI board's audit committee. Ms. Willetts has been an advisory director of Goldman, Sachs & Co. since July [...]
